Welcome to MCL!

This is the Consortium for Molecular and Cellular Characterization of Screen-Detected Lesions.

The MCL Consortium consists of independent, multi-disciplinary teams that undertake comprehensive molecular and cellular characterizations of tumor tissue, cell, and microenvironment components to distinguish screen-detected early lesions from interval and symptom-detected cancers.

If you'd like to join us, fill out the registration form.

 


 

COMING UP SOON:

MCL 5th Semiannual Steering Committee Meeting

The MCL Consortium will hold its 5th Face-to-Face Steering Committee Meeting in conjunction with EDRN. Be sure to register for the meeting and reserve a room.

Note: the registration form may be blocked by certain institutional firewalls. If you cannot register, try again at home or elsewhere.